| 000 | 06887cam a2200601Ii 4500 | ||
|---|---|---|---|
| 001 | ocn910159094 | ||
| 003 | OCoLC | ||
| 005 | 20190328114811.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 150527s2015 enka ob 001 0 eng d | ||
| 040 |
_aN$T _beng _erda _epn _cN$T _dIDEBK _dN$T _dOPELS _dYDXCP _dEBLCP _dCDX _dABH _dDEBSZ _dOCLCQ _dN$T _dLVT _dVGM _dOCLCO _dMERER _dOCLCO _dOCLCQ _dS3O _dOCLCQ _dOCLCA _dU3W _dOCLCO _dD6H _dOCLCF _dCHVBK _dOCLCO _dAU@ _dOCLCO _dWYU _dOCLCO _dOCLCQ _dOCLCA _dCUY _dLOA _dZCU _dMERUC _dICG _dUSU _dOCLCO _dK6U _dCOCUF _dOCLCQ _dOCLCO _dVT2 _dDKC |
||
| 019 |
_a910447567 _a917876408 _a1066467755 |
||
| 020 |
_a9780128014714 _q(electronic bk.) |
||
| 020 |
_a0128014717 _q(electronic bk.) |
||
| 020 | _z9780128013175 | ||
| 020 | _a0128013176 | ||
| 020 | _a9780128013175 | ||
| 035 |
_a(OCoLC)910159094 _z(OCoLC)910447567 _z(OCoLC)917876408 _z(OCoLC)1066467755 |
||
| 050 | 4 | _aRC113.3 | |
| 060 | 4 | _aWC 100 | |
| 072 | 7 |
_aHEA _x039040 _2bisacsh |
|
| 072 | 7 |
_aMED _x022090 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.90475 _223 |
| 245 | 0 | 0 |
_aNanotechnology in diagnosis, treatment and prophylaxis of infectious diseases / _h[electronic resource] _cedited by Mahendra Rai, Kateryna Kon. |
| 264 | 1 |
_aLondon : _bAcademic Press is an imprint of Elsevier, _c2015 |
|
| 300 |
_a1 online resource : _billustrations (some color) |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 588 | 0 | _aOnline resource; title from PDF title page (Ebsco, viewed May 29, 2015). | |
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aFront Cover; Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases; Copyright Page; Contents; List of Contributors; Preface; 1 Gold and Silver Nanoparticles for Diagnostics of Infection; 1.1 Nanotechnology and Infection; 1.2 Gold and Silver NPs for Molecular Diagnostics; 1.2.1 Biomarkers; 1.3 Nanodiagnostics for Nucleic Acids; 1.3.1 Homogeneous Colorimetric Assays; 1.3.1.1 Unmodified NPs; 1.3.1.2 Cross-Linking; 1.3.1.3 Noncross-Linking; 1.3.2 Heterogeneous Detection; 1.3.2.1 Microarrays; 1.3.2.2 Lateral Flow Assays; 1.3.3 Electrochemical Assays. | |
| 505 | 8 | _a1.3.4 Fluorescence Assays1.3.5 Raman and SERS; 1.3.6 Other; 1.4 Aptamers and Antibodies; 1.4.1 Colorimetric; 1.4.2 Electrochemical; 1.4.3 Lateral Flow Assays; 1.5 iPCR and Other Methods; 1.6 Conclusion; References; 2 Antimicrobial Models in Nanotechnology: From the Selection to Application in the Control and Treatment of Infectious Diseases; 2.1 Introduction; 2.2 Antimicrobial Susceptibility Testing Methods of NMs; 2.2.1 Broth Dilution Test; 2.2.2 Spectrophotometric Measurement; 2.2.3 Cell Counting; 2.2.4 Colorimetric and Fluorescent Assays; 2.2.5 In Vitro Infection Animal Model. | |
| 505 | 8 | _a2.2.6 Biocidal Testing2.2.7 Antibiofilm Activity; 2.2.8 Quorum-Sensing Inhibitors; 2.2.9 Microbial Membrane Lysis; 2.2.10 Microbial Oxidative Stress; 2.2.11 Antipersister and Antidormancy Bacterial Cells; 2.2.12 Microbial Fitness; 2.3 Nanotoxicology; 2.3.1 Nano-Genotoxicology; 2.3.2 Cytotoxicity; 2.3.3 Immunotoxicity; 2.3.4 In Vitro Skin Irritation; 2.3.5 Caenorhabditis elegans Toxicity Model; 2.3.6 Nanotoxicity in Embryonic and Adult Zebrafish; 2.3.7 Bioluminescence-Based Nanotoxicity Test; 2.4 In Vitro Pharmacokinetics/Pharmacodynamic Models; 2.4.1 Particokinetics; 2.4.2 Caco-2 Permeability. | |
| 505 | 8 | _a2.4.3 Hollow Fiber System2.5 Conclusions; References; 3 Silver Nanoparticles for the Control of Vector-Borne Infections; 3.1 Introduction; 3.2 Louse-Borne Infections and Activity of AgNPs Against Lice; 3.3 Mosquito-Borne Infections and Activity of AgNPs Against Mosquitoes; 3.4 Tick-Borne Infections and Activity of AgNPs Against Ticks; 3.5 Flies, Their Role in Transmission and Spread of Infections, and Activity of AgNPs Against Flies; 3.6 Conclusions and Future Prospects; References; 4 Magnetite Nanostructures: Trends in Anti-Infectious Therapy; 4.1 Introduction. | |
| 505 | 8 | _a4.2 Nanoparticles with Biomedical Applications4.2.1 Design of Tailored Magnetic Nanoparticles with Applications in Microbiology; 4.2.2 Magnetite Nanoparticles Used to Control Microorganisms Attachment and Biofilm Formation; 4.2.3 The Biocompatibility of Magnetite Nanoparticles; 4.2.3.1 Biocompatibility Evaluation of Magnetite Nanoparticles at the Cellular Level; 4.2.3.2 Biocompatibility Evaluation of Magnetite Nanoparticles at Biochemical and Molecular Level; 4.2.3.3 Biocompatibility Evaluation of Magnetite Nanoparticles Using Animal Models; 4.3 Conclusions; References. | |
| 520 | 8 | _aNanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases delivers comprehensive coverage of the application of nanotechnology to pressing problems in infectious disease. This text equips readers with cutting-edge knowledge of promising developments and future prospects in nanotechnology, paying special attention to microbes that are now resistant to conventional antibiotics, a concerning problem in modern medicine. Readers will find a thorough discussion of this new approach to infectious disease treatment, including the reasons nanotechnology presents a promising avenue for the diagnosis, treatment, and prophylaxis of infectious diseases. Provides a comprehensive overview of the use of nanotechnology in the treatment and diagnosis of infectious diseasesCovers all common types of infective agents, including bacteria, viruses, fungi, and protozoa, along with their vectors, ticks, mosquitoes, flies, etc. Delivers commentary from an international researcher base, providing insights across differing economic statusesIncludes a foundation of basic nanotechnological concepts to aid in designing new strategies to combat several pathogenic diseases and cancerIllustrates the high antimicrobial potential of nanoparticles, ultimately demonstrating how they are a promising alternative class that can be successfully used in fighting a myriad of infections. | |
| 650 | 0 |
_aCommunicable diseases _xDiagnosis _xTechnological innovations. |
|
| 650 | 0 |
_aCommunicable diseases _xTreatment _xTechnological innovations. |
|
| 650 | 0 | _aNanomedicine. | |
| 650 | 7 |
_aHEALTH & FITNESS _xDiseases _xContagious. _2bisacsh |
|
| 650 | 7 |
_aMEDICAL _xInfectious Diseases. _2bisacsh |
|
| 650 | 7 |
_aNanomedicine. _2fast _0(OCoLC)fst01744350 |
|
| 650 | 2 |
_aCommunicable Diseases. _0(DNLM)D003141 |
|
| 655 | 4 | _aElectronic books. | |
| 655 | 0 | _aElectronic books. | |
| 655 | 7 |
_aElectronic books. _2lcgft |
|
| 700 | 1 |
_aRai, Mahendra, _eeditor. |
|
| 700 | 1 |
_aKon, Kateryna Volodymyrivna, _eeditor. |
|
| 776 | 0 | 8 |
_iPrint version: _aRai, Mahendra. _tNanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases. _dBurlington : Elsevier Science, �2015 _z9780128013175 _w(OCoLC)903596380 |
| 856 | 4 | 0 |
_3ScienceDirect _uhttp://www.sciencedirect.com/science/book/9780128013175 |
| 999 |
_c247090 _d247090 |
||